Range Low Price High Price Comment
30 days $36.77 $55.69 Wednesday, 1st May 2024 BHVN stock ended at $40.18. This is 3.56% more than the trading day before Tuesday, 30th Apr 2024. During the day the stock fluctuated 8.34% from a day low at $38.43 to a day high of $41.64.
90 days $36.77 $62.21
52 weeks $13.03 $62.21

Historical Biohaven Pharmaceutical Holding Company Ltd prices

Date Open High Low Close Volume
Oct 31, 2023 $27.36 $27.47 $25.97 $26.51 1 183 410
Oct 30, 2023 $26.97 $28.07 $26.87 $27.63 546 796
Oct 27, 2023 $28.10 $28.20 $26.69 $26.84 1 097 489
Oct 26, 2023 $27.61 $28.80 $27.61 $27.99 1 081 248
Oct 25, 2023 $27.47 $28.41 $27.21 $27.65 521 962
Oct 24, 2023 $26.94 $28.11 $26.94 $27.91 841 354
Oct 23, 2023 $27.10 $27.60 $26.65 $26.85 1 264 119
Oct 20, 2023 $26.84 $28.00 $26.30 $27.37 1 229 704
Oct 19, 2023 $27.59 $27.93 $26.82 $26.94 845 396
Oct 18, 2023 $27.83 $28.26 $27.24 $27.51 698 160
Oct 17, 2023 $26.94 $28.85 $26.87 $27.92 1 092 851
Oct 16, 2023 $27.19 $28.49 $26.56 $27.39 1 248 271
Oct 13, 2023 $26.94 $27.67 $26.10 $27.14 1 170 960
Oct 12, 2023 $27.66 $27.94 $25.39 $26.13 1 631 132
Oct 11, 2023 $26.48 $27.70 $26.31 $27.70 1 373 082
Oct 10, 2023 $25.41 $26.53 $24.60 $26.13 1 054 181
Oct 09, 2023 $23.96 $25.29 $23.73 $24.85 1 067 493
Oct 06, 2023 $24.65 $24.65 $23.51 $24.02 1 296 650
Oct 05, 2023 $22.81 $24.41 $22.38 $24.15 1 541 791
Oct 04, 2023 $23.16 $23.52 $22.12 $22.93 1 527 877
Oct 03, 2023 $23.20 $23.74 $22.58 $23.22 2 833 009
Oct 02, 2023 $26.10 $26.48 $24.06 $24.07 1 134 605
Sep 29, 2023 $26.32 $27.40 $25.65 $26.01 2 069 519
Sep 28, 2023 $23.52 $26.09 $23.21 $26.01 2 644 325
Sep 27, 2023 $20.80 $25.48 $20.80 $23.53 6 435 907
Click to get the best stock tips daily for free!

About Biohaven Pharmaceutical Holding Company Ltd

Biohaven Pharmaceutical Holding Company Ltd Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavegepant that is in phase III clinical trials for acute and preventive treatment of migraine, as well as re... BHVN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT